Jm. Kramer et al., Disseminated vaccine strain varicella as the acquired immunodeficiency syndrome-defining illness in a previously undiagnosed child, PEDIATRICS, 108(2), 2001, pp. NIL_136-NIL_139
The Food and Drug Administration licensed a live-virus varicella vaccine (V
arivax; Merck & Co Inc, West Point, PA) in March 1995. Prelicensure adverse
events were minimal; however, since licensure and increased vaccine use, r
are previously undetected risks have arisen. Presented here is the clinical
course of a previously undiagnosed, human immunodeficiency virus-infected
boy who developed dissemination of the vaccine strain of varicella zoster a
fter immunization.